Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer and EVP
-
Stock Symbol
-
MCRB on Nasdaq
Matthew R. Henn - trading volume in the past year for Seres Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
67.2K |
$56.5K |
$0.84 |
Aug 16, 2024 |
Direct |
|
|
Restricted Stock Units |
28.1K |
$23.6K |
$0.84 |
Aug 15, 2024 |
Direct |
Common Stock |
|
Stock Option (Right to Buy) |
288K |
|
|
Feb 14, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.